Evidence map›Paper›PMID 35749867›Full record

ArticleAddictive behaviors2022

Correlates of tobacco product initiation among youth and young adults between waves 1-4 of the population assessment of tobacco and Health (PATH) study (2013-2018).

Maria Cooper, Hannah R Day, Chunfeng Ren, Olusola Oniyide, Catherine G Corey, Bridget K Ambrose, K Michael Cummings, James Sargent, Ray Niaura, John P Pierce and 16 more

Erratum issuedAbstract read
In one paragraph

Article in Addictive behaviors, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Maria CooperUS Food and Drug Administration, Center for Tobacco Products, United States. Electronic address: Maria.Cooper1@fda.hhs.gov.
Hannah R DayUS Food and Drug Administration, Center for Tobacco Products, United States.
Chunfeng RenUS Food and Drug Administration, Center for Tobacco Products, United States.
Olusola OniyideUS Food and Drug Administration, Center for Tobacco Products, United States.
Catherine G CoreyUS Food and Drug Administration, Center for Tobacco Products, United States.
Bridget K AmbroseUS Food and Drug Administration, Center for Tobacco Products, United States.
K Michael CummingsMedical University of South Carolina, Department of Psychiatry & Behavioral Sciences, United States.
James SargentDartmouth Medical School, Data Sciences Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center, United States.
Ray NiauraNew York University, College of Global Public Health, United States.
John P PierceUniversity of California, San Diego, Herbert Wertheim School of Public Health, United States.
Annette KaufmanDivision of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, United States.
Kelvin ChoiDivision of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, United States.
Maciej L GoniewiczRoswell Park Comprehensive Cancer Center, United States.
Cassandra A StantonWestat, Behavioral Health and Health Policy, United States.
Andrea VillantiRutgers School of Public Health, United States.
Karin KaszaRoswell Park Comprehensive Cancer Center, United States.
Maansi Bansal-TraversRoswell Park Comprehensive Cancer Center, United States.
Marushka L SilveiraDivision of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, United States; Kelly Government Solutions, United States.
Heather L KimmelDivision of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, National Institutes of Health, United States.
Lynn C HullUS Food and Drug Administration, Center for Tobacco Products, United States.
Amber KoblitzUS Food and Drug Administration, Center for Tobacco Products, United States.
Karl PoonaiUS Food and Drug Administration, Center for Tobacco Products, United States.
Antonio ParedesUS Food and Drug Administration, Center for Tobacco Products, United States.
Kristie TaylorWestat, Behavioral Health and Health Policy, United States.
Nicolette BorekUS Food and Drug Administration, Center for Tobacco Products, United States.
Andrew J HylandRoswell Park Comprehensive Cancer Center, United States.

Funding

Understanding and reducing tobacco-related health disparities through social and behavioral researchZIAMD000006 · NIMHD · NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES · PI CHOI, KELVIN · 2015 to 2025
$7.0M
Intramural FDA HHS FD999999
6 · The paper itself

Abstract

introductionWhile risk factors for cigarette smoking among youth and young adults are well-documented, less is known about the correlates of initiation of other tobacco products. This study aims to provide estimates and correlates of initiation among U.S. youth and young adults.

methodsData on youth aged 12-17 (n = 10,072) and young adults aged 18-24 (N = 5,727) who provided information on cigarettes, electronic nicotine delivery systems (ENDS), cigars, pipe, hookah and smokeless tobacco use in Wave 1 (W1: 2013-2014)-Wave 4 (W4: 2016-2018) of the nationally-representative PATH Study were used to calculate ever use initiation and correlates of initiation by W4.

resultsNearly 6 million youth and 2.5 million young adults used tobacco for the first time between W1-W4. Approximately one quarter of youth and young adult ENDS never users initiated ENDS between W1-W4 of the PATH Study. Among youth, use of other tobacco products, ever substance use, and high externalizing problems were associated with initiation of most products. Among young adults, use of other tobacco products and ever substance use were associated with initiation of most products. In both youth and young adults, Hispanics were more likely to initiate hookah use than their non-Hispanic White counterparts. While male sex was a risk factor for most tobacco product initiation across both age groups, it was not associated with hookah initiation.

conclusionsCigarette and non-cigarette products shared many correlates of initiation, although there are noteworthy demographic differences. Findings can help tailor product specific interventions to reach populations at risk during preliminary stages of use.

Indexed as

Cigarette SmokingElectronic Nicotine Delivery SystemsSubstance-Related DisordersTobacco ProductsAdolescentHumansMaleTobacco UseUnited StatesYoung AdultEpidemiologic surveillanceLongitudinal researchTobacco useYouth and young adults

Identifiers

PMID35749867
PMCPMC9726988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.